General Information of the Compound
| Compound ID |
CP0861154
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-5-benzyl-3-((R)-1-(4-fluorophenyl)ethyl)-5-(5-(3-methylisoxazol-4-yl)-1H-benzo[d]imidazol-2-yl)oxazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H23FN4O4
|
||||||||||||||||||
| Molecular Weight |
510.525
|
||||||||||||||||||
| Canonical SMILES |
Cc1nocc1-c1ccc2[nH]c([C@@]3(Cc4ccccc4)OC(=O)N([C@H](C)c4ccc(F)cc4)C3=O)nc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H23FN4O4/c1-17-23(16-37-33-17)21-10-13-24-25(14-21)32-26(31-24)29(15-19-6-4-3-5-7-19)27(35)34(28(36)38-29)18(2)20-8-11-22(30)12-9-20/h3-14,16,18H,15H2,1-2H3,(H,31,32)/t18-,29-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XSOMCGRRWBDXDY-LDLUVENISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Protein ID: PT00886, Estrogen receptor
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01154, Mineralocorticoid receptor
Protein ID: PT01172, Progesterone receptor